According to Immunovant, the medicine, batoclimab, succeeded in a Phase 3 study of patients with myasthenia gravis and the first part of a Phase 2b trial focused on an immune condition that damages ...

"All three types of myasthenia gravis, based on antibody status ... "With that said, MuSK MG is known for a predilection of bulbar symptoms, such as swallowing and speech problems," he continued.

Generalised myasthenia gravis (gMG) is a chronic disorder in which the body's immune system mistakenly targets the neuromuscular junctions—areas where nerves signal muscles to move. This ...

With what analysts are calling “strong” data, Amgen plans to file a regulatory submission for Uplizna, currently approved for a rare ocular autoimmune disorder, in myasthenia gravis, in the first half ...